ArticleScientific reports2025
Prediction of exosomal miRNA-based biomarkers for liquid biopsy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Human biomarker navigator.iMeta · 2026Review
- Oral Microbial Extracellular Vesicles as Novel Mediators of Alzheimer's Pathogenesis: A Critical Review of the Periodontal-Brain Axis.Neurotoxicity research · 2026Review
- Review
- Isolation of Exosomes from MDA-MB-231 Cells Using a Paddle Screw System and Detection of TNBC-Associated Exosomal miRNAs.Micromachines · 2026Article
- Diet-Driven Epigenetic Alterations in Colorectal Cancer: From DNA Methylation and microRNA Expression to Liquid Biopsy Readouts.Biomedicines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we investigated the properties of exosomal miRNAs to identify potential biomarkers for liquid biopsy. We collected 956 exosomal and 956 non-exosomal miRNA sequences from RNALocate and miRBase to develop predictive models. Our initial analysis reveals that specific nucleotides are preferred at certain positions in miRNAs associated with exosomes. We employed an alignment-based approach, artificial intelligence (AI) models, and ensemble methods for predicting exosomal miRNAs. For the alignment-based approach, we used a motif-based method with MERCI and a similarity-based method with BLAST, achieving high precision but low coverage of about 29%. The AI models, developed using machine learning, deep learning techniques, and pretrained language models, achieved a maximum AUC of 0.707 and an MCC of 0.268 on an independent dataset. Finally, our ensemble method, combining alignment-based and AI-based models, reached a maximum AUC of 0.73 and an MCC of 0.352 on an independent dataset. We have developed a web server, EmiRPred, to assist the scientific community in predicting and designing exosomal miRNAs and identifying associated motifs ( https://webs.iiitd.edu.in/raghava/emirpred/ ).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.